Quinolones Industry Revenue to Reach $63.17 Billion by 2029 with CAGR of 5% (2025–2029)

 

Quinolones Market

Claim 20% Off With Code ONLINE20 – Explore Market Reports Covering Trade Trends, Regulatory Changes, and Growth Insights

What Is the Current Market Size and Growth Rate of the Quinolones Market?

The quinolones market size has grown steadily in recent years. It will grow from $50.05 billion in 2024 to $51.89 billion in 2025 at a compound annual growth rate (CAGR) of 3.7%. The growth in the historic period can be attributed to antibiotic demand and usage, regulatory approvals, research and development, competitive landscape, patent expirations.

The quinolones market size is expected to see strong growth in the next few years. It will grow to $63.17 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to emerging diseases, regulatory changes, global health policies, rising antibiotic resistance, and market expansion strategies. Major trends in the forecast period include new product development, and changes in the regulatory landscape.

Claim your free report sample now:

Which Factors Are Driving Growth in the Quinolones Market?

The rise in the incidence of infectious diseases is significantly contributing to the growth of the quinolones market. Infectious diseases refer to illnesses brought on by microbes such as parasites, fungi, bacteria, and viruses. Quinolones are widely used for treating a variety of infectious diseases caused by bacteria such as tuberculosis and urinary tract infections. For instance, in November 2023, according to the Global Tuberculosis Report published by the World Health Organization, a Switzerland-based health agency, the global number of newly diagnosed TB cases reached 7.5 million in 2022, marking an increase from 6.4 million in 2021. Therefore, the rise in the incidence of infectious diseases will drive the quinolones market.

What Are the Core Segments Shaping the Quinolones Market Landscape?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Norfloxacin: Indications, Dosage Forms

2) By Ofloxacin: Indications, Dosage Forms

3) By Ciprofloxacin: Indications, Dosage Forms

4) By Gemifloxacin: Indications, Dosage Forms

5) By Other Types: Various Formulations, Indications

What Are the Top Trends Expected to Shape the Quinolones Market by 2029?

Product innovation is the key trend gaining popularity in the quinolones market. Major companies operating in the quinolones market are focusing on developing innovative products to sustain their market position. For instance, in January 2023, the South Korean branch of Viatris, a US-based pharmaceutical company launched Dovprela, a new drug-resistant tuberculosis treatment. Dovprela is a three-drug regimen of bedaquiline, pretomanid, and linezolid (BPaL) for treating adult patients with extensively drug-resistant TB and treatment-resistant or non-responsive multidrug-resistant TB. Dovprela reduces the treatment period from 18-20 months to 5-6 months due to its rapid anti-tuberculosis effect.

Which Are the Top Companies in the Quinolones Market?

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Get the full quinolones market report here:

Which Regions Are Driving the Most Demand in the Quinolones Market?

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Contact Us:

The Business Research Company

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

Comments